Phase I–IV Clinical Trials
Clinical trial software for Phase I–IV studies
oomnia supports Phase I–IV clinical trials within a single, consistent environment that adapts to each stage of development, ensuring control, compliance, and continuity across the full clinical lifecycle.
Unified Approach
Why managing Phase I–IV trials in one system matters
Clinical development programs run across multiple phases and timelines, often requiring teams to change systems and processes along the way.
This phase-by-phase approach leads to fragmented data, duplicated setup efforts, and reduced visibility across the full clinical lifecycle.
A single clinical trial software, built as a Clinical Research Information System (CRIS), used across Phase I–IV ensures continuity in data and processes, reducing friction as clinical trial programs move forward.
Modular eClinical systems
Different systems used across Phase I–IV trials
Data fragmented between phases and study stages
Repeated setup and reconfiguration at each phase
Limited visibility across the full clinical lifecycle
Unified Clinical Trial Software (oomnia)
One system supporting all clinical trial phases
Continuous data consistency from Phase I through Phase IV
Reusable workflows and study structures
Full traceability across the entire clinical development lifecycle
Clinical Phases
One clinical trial platform across every trial phase
Instead of switching systems or processes as trials progress, oomnia enables a consistent operational and data framework that scales from early feasibility through long-term safety and effectiveness studies
Phase I trials
- Clear oversight of first-in-human and dose-escalation studies
- Structured data capture and real-time study visibility
- Strong traceability to support safety reporting and audits
- Support for rapid protocol adjustments in early-phase studies
Phase II trials
- Manage growing operational complexity without losing control
- Maintain consistent data standards across sites and regions
- Align trial execution with regulatory expectations early on
- Structured progression from early safety to efficacy evaluation
Phase III trials
- Centralized oversight of large, multi-regional study portfolios
- Integrated trial operations, data management, and documentation
- Continuous inspection readiness throughout lengthy trial timelines
- Coordination across multiple vendors and regions within one system
Phase IV trials
- Ongoing data collection and monitoring across extended timelines
- Regulatory-ready documentation for post-marketing obligations
- Structured oversight of decentralized or observational designs
Side by Side
Managing clinical trials phase by phase vs a unified approach
| Area | Modular eClinical system | Unified clinical trial software (oomnia) |
|---|---|---|
| Systems | Different systems used across phases | One system across Phase I–IV |
| Data consistency | Data fragmentation between phases | Continuous data consistency |
| Study setup | Reconfiguration at each phase | Reusable structures and workflows |
| Traceability | Limited end-to-end visibility | Full data traceability across lifecycle |
| Operational risk | Increased risk during transitions | Reduced risk with no system changes |
| Efficiency | Rework and delays between phases | Faster progression between phases |
Regulatory Readiness
Designed for regulated research environments
oomnia supports global regulatory expectations through structured controls and validated processes
Aligned with GxP principles
Supports GxP-aligned processes across all Phase I–IV clinical research operations
Supports compliance with 21 CFR Part 11
Fully compatible with 21 CFR Part 11 electronic records and signature requirements across trial phases
ICH-GCP-compliant workflows and oversight controls
Workflows structured in accordance with ICH-GCP standards, supporting oversight across all study sites and phases
GDPR-aligned data handling and privacy safeguards
GDPR-compliant data handling and privacy protection across all clinical trial environments
Built-in audit trails and full data traceability
Automatic audit trails and complete data traceability across all clinical development phases and operations
Validation documentation and continuous system compliance support
Clear validation documentation and ongoing support to maintain compliance across Phase I–IV trial configurations
Who We Serve
Supporting Phase I–IV trials across research organizations
Wemedoo supports Phase I–IV clinical trials for organizations operating across research and regulated industries, addressing varying levels of complexity, scale, and compliance requirements throughout the clinical development lifecycle
Centralized oversight of extensive, multi-regional Phase I–IV trial portfolios
Flexible, scalable infrastructure to support progression from early-phase studies to late-stage trials
Streamlined execution and improved operational visibility across clinical development stages
Simplified delivery of Phase I–IV trials by consolidating fragmented systems and processes
Practical, efficient workflows designed for investigator-led and resource-limited clinical research
Coordinated management of operations and data across sites, departments, and trial phases
Structured support for safety, quality, and regulatory studies across development stages
Consistent frameworks for safety assessment and product substantiation throughout clinical evaluation
End-to-end enablement of veterinary trials from early research through post-approval studies
Controlled management of substantiation and compliance studies across development phases
Trusted partners
Global network of partners
Clinical Development Strategy
Beyond traditional clinical trials
Clinical research often goes beyond traditional Phase I–IV trials. Wemedoo supports this through decentralized study designs and real-world data studies, using one unified framework to ensure control, data quality, and regulatory readiness.
The Platform
Clinical trial software supporting every phase
oomnia connects trial operations, data capture, and documentation together in one environment, supporting clinical trials from early development to post-market studies
EDC software
Unified Electronic Data Capture system for compliant, real-time clinical data collection
CTMSCTMS software
Automated trial management solution designed to streamline study oversight
ETMFeTMF software
Digital workspace for storing, managing, and accessing trial master file documents
ECONSENTeConsent software
Electronic informed consent solution designed for seamless participant consent capture
EPROePRO software
Real-time electronic patient-reported outcomes solution for patient data entry
ECOAeCOA software
Capture patient-reported outcomes, clinician assessments, and study data in real time without paper workflows
RTSMRTSM software
Randomization and Trial Supply Management system that automates treatment allocation and blinding in real-time
ESOURCEeSource clinical trials
Electronic source system that captures original site data in real time, fully validated and without manual transcription
Therapeutic Areas
Built to support trials across therapeutic areas
oomnia supports clinical development across a wide range of therapeutic areas within a single unified platform, whether studies are early-stage, late-stage, or post-market.
This approach allows teams to run Phase I through Phase IV studies across multiple therapeutic domains while maintaining consistent data standards, streamlined operations, and centralized oversight throughout the clinical lifecycle.
Get Started
Moving seamlessly from Phase I to Phase IV
Clinical development is continuous. Your systems should be too.
Talk to our team